Endomag – Everyone deserves a better standard of cancer care

Endomag has worked very closely with breast cancer surgeons and radiologists to create a better standard of care and outcomes for breast cancer patients. Their Magseed marker is fast becoming the new standard in breast cancer treatment. The Endomag breast cancer lymphatic tracer, Magtrace, offers patients a radiation-free sentinel lymph node biopsy. The Endomag Magtrace has again made headlines after recently receiving a positive Medtech Innovation Briefing (MIB) from the UK National Institute for Health and Care Excellence (NICE). Magtrace is the first-ever tracer to obtain a positive endorsement from NICE.  Link to article

Click here for Clinical Reference papers 

If you would like to learn more about how this fantastic technology can help to improve the outcomes for our breast cancer patients in New Zealand, please contact our Surgical team at Obex Medical 0800-656-239 or info@obex.co.nz